Ingram Micro aims to accelerate growth into $40 billion market for e-commerce fulfillment services, through acquisition of Shipwire, a logistics services company backed by eBay and Newell Rubbermaid.
Month: October 2013
Criteo IPO pops
French advertising technology company Criteo raises $250.6m on Nasdaq after twice upping its IPO price and closing higher still.
Samsung alive to Novasentis
Novasentis, developer of technology to create flexible, sensory phones and other devices, raises $8m led by Samsung Ventures.
Ascension identifies PathoGenetix potential
PathoGenetix, developer of a system of rapid bacterial identification for use in food safety and beyond, raises $10m series C funding from investors including Ascension Health Ventures, to commercialize its technology.
Adaptive Planning adds Salesforce.com
Business analytics software provider Adaptive Planning expands $45m funding round to include investments from Salesforce.com and former CFO of Oracle, Jeff Epstein.
VSee gains Salesforce backing
Aside from Salesforce, In-Q-Tel has invested in the business, according to TechCrunch.
Visible shows $24m round
News provider Dow Jones said Visible Technologies raised close to $24m, according to an SEC filing. Part of the money was used to fund the acquisition of Cymfony, which Visible announced in April.
Teradici calls up IQT
Teradici has reportedly raised about $63m from venture capital firms Alloy Ventures, Alta Berkeley, BDC Venture Capital, GrowthWorks Capital and Skypoint Capital, in addition to Telus Ventures and IQT.
T2 Biosystems tests its $40m
US-based medical diagnostics company T2 Biosystems has raised $40m in its series E round including new investor, investment bank Goldman Sachs. The money will help develop T2Candida, the company’s molecular diagnostic test of species-specific Candida fungal infections directly from whole blood. In 2001, T2 closed a $23m series D round of financing led by US-based… Continue reading T2 Biosystems tests its $40m
Palantir adds nearly $200m
This takes the funding for the publisher Reed Elsevier-backed Palantir to a reported $498m for a business that was expected to turn over about $400m last year.
Wayra puts faith in Trustev
Trustev, an Ireland-based technology startup which provides e-commerce security and online fraud protection, has closed a $3m seed funding round from investors including Wayra, the business accelerator run by Spain-based telecommunications company Telefónica, Enterprise Ireland, an Irish state economic development agency, and venture capital investors Greycroft Partners, Mangrove Capital Partners and ACT Venture Capital. Pat… Continue reading Wayra puts faith in Trustev
Anterra Capital debuts with It’sFresh!
Anterra Capital, a Netherlands-based food & agriculture (F&A) innovation fund, has been formed through the spin-out of Rabobank’s proprietary venture capital investment team, Rabo Ventures. Rabobank will remain a cornerstone investor in Anterra alongside incoming investor Moonray Investors, the proprietary investment arm of FIL Limited, the parent company of Fidelity Worldwide Investment. Nicky McCabe, chief… Continue reading Anterra Capital debuts with It’sFresh!
DaVita HealthCare Partners joins J&J in backing CVRx
Medical device company CVRx extends series F financing to $42m, with extra $12m from investors including DaVita HealthCare Partners, in order to advance clinical trials for its system to treat hypertension and heart failure.
Sanofi-Genzyme joins Immune Design syndicate
Immune Design raises up to $49m series C financing from a syndicate including new investor Sanofi-Genzyme BioVentures, to advance its cancer immunotherapy product pipeline.